Want to see JSPR full AI Analyst Report?
Briquilimab
Urticaria Chronic
Phase II
Enrolling By Invitation
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
Nov 20, 2024
―
Briquilimab
Allergic Asthma
Phase I
Terminated
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Sep 06, 2024
―
Briquilimab
Chronic Inducible Urticaria
Phase I/II
Terminated
A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Apr 03, 2024
―
Briquilimab
Chronic Spontaneous Urticaria
Phase I/II
Recruiting
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
Nov 21, 2023
―
Jsp191
Lower-Risk Myelodysplastic Syndrome
Phase I
Terminated
JSP191 (briquilimab) in Subjects with LR-MDS
Jun 05, 2023
―
Humanized Anti-Cd117 Monoclonal Antibody (Jsp191)
Scid
Phase I/II
Terminated
JSP191 Antibody Targeting Conditioning in SCID Patients
Nov 02, 2016
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Jasper Therapeutics (JSPR) have in its pipeline
JSPR is currently developing the following drugs: Briquilimab, Briquilimab, Briquilimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.